Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Glioblastoma × Saline Solution × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 10 Prostatic Neoplasms 5 Ovarian Neoplasms 5 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 3 Lung Neoplasms 2 Leukemia, Myeloid, Acute 2 Fallopian Tube Neoplasms 2 Colorectal Neoplasms 2 Vomiting 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thromboembolism 1 Stomatitis 1 Stomach Neoplasms 1 Spondylitis, Ankylosing 1 Small Cell Lung Carcinoma 1 Skin Neoplasms 1 Psoriasis 1 Postoperative Hemorrhage 1 Pleural Effusion 1 Peritoneal Neoplasms 1 Pancreatic Cyst 1 Pain 1 Otolaryngeal Cancer 1 Leukemia 1 Kidney Neoplasms 1 Hyperparathyroidism 1

Interventions

Temozolomide 104 Bevacizumab 64 Radiotherapy 45 Radiation 21 Erlotinib Hydrochloride 12 pembrolizumab 10 Magnetic Resonance Spectroscopy 10 Lomustine 10 Vorinostat 9 Irinotecan 9 Nivolumab 8 Surgical Procedures, Operative 7 Radiotherapy, Intensity-Modulated 7 Immunoglobulin G 7 Disulfides 7 Sorafenib 6 Radiotherapy, Conformal 6 Radiosurgery 6 Drug Therapy 6 Carmustine 6 antineoplaston AS 2-1 5 antineoplaston A10 5 Granulocyte-Macrophage Colony-Stimulating Factor 5 Everolimus 5 veledimex 4 selinexor 4 sargramostim 4 cediranib 4 Dasatinib 4 Cilengitide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02465268 2025-01-14

ATTAC-II

University of Florida

Phase 2 Completed

175 enrolled 18 charts

Glioblastoma, Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡